1 citations
,
January 2020 in “International journal of research in pharmacy and chemistry” This review provides an overview of the ethnomedicinal uses, chemical composition, and pharmacological profile of Eclipta alba Hassk and presents no new clinical findings.
May 2023 in “GSC Advanced Research and Reviews” This review highlights the diverse pharmacological properties of Eclipta alba, often used traditionally in Asian medicine, detailing its hepatoprotective, hair growth promoting, antidiabetic, and other therapeutic activities linked to its chemical compounds such as wedelolactone.
August 2026 in “Plant Science Today” This review synthesizes data on Eclipta alba, highlighting its traditional use for liver, skin, and general health, supported by preclinical evidence of hepatoprotective and other beneficial activities, while noting the need for more rigorous toxicological and clinical safety studies to substantiate its therapeutic applications.
This review discusses the medicinal uses and phytochemical composition of Eclipta alba and reports no new clinical findings; the authors suggest its potential therapeutic significance due to complex interactions of its constituents.
May 2023 in “Zenodo (CERN European Organization for Nuclear Research)” In this review, researchers synthesized current knowledge on Eclipta alba (Bhringaraja) from traditional Ayurvedic texts and scientific literature, reporting its wide range of pharmacological properties, including hepatoprotective, antioxidant, antimicrobial, and anticancer effects, attributed to its chemical compounds like wedelolactone.